Article

The Role of CARD15 Mutations and Smoking in the Course of Crohn's Disease in a Mediterranean Area

Ematologia II Ospedale V. Cervello, Palermo, Italy.
The American Journal of Gastroenterology (Impact Factor: 9.21). 04/2008; 103(3):649-55. DOI: 10.1111/j.1572-0241.2007.01589.x
Source: PubMed

ABSTRACT To evaluate the role of CARD15 mutations and smoking in the main events of Crohn's disease (CD).
A total of 182 patients with CD were included in a prospective study in order to evaluate the role of CARD15 mutations and smoking in the main outcomes of disease course: first operation and surgical recurrence. The following variables were evaluated in a univariable and multivariable analysis: age, sex, site of disease, pattern, smoking habit, extraintestinal manifestations, duration of disease, and CARD15 mutation. The Kaplan-Meier method for survival curves and Cox model for multivariable analysis were, respectively, used.
A total of 110 patients were operated on and 32 were reoperated on. The 7-yr cumulative free rate of surgery was 42% (95% CI 34-51%). At multivariate analysis only stricturing and penetrating pattern were predictors of surgery (HR 1.7, 95% CI 1-2.8; HR 3.2, CI 1.8-5.5, respectively). The 7-yr cumulative free rate of reoperation was 75% (95% CI 0.52-0.88). At multivariable analysis in the model with any CARD15 mutation, only smoking habit at diagnosis (HR 3.6, 95% CI 1.4-9.1) was predictive of surgical recurrence. When single mutations were considered in the model smoking (HR 4.2, 95% CI 1.8-10.1) and L1007fs mutation (HR 2.9, 95% CI 1.1-7.3) were predictive of reoperation.
In CD, smoking predicts recurrence after surgery. The role of CARD15 mutations in the clinical course of CD remains undefined.

0 Followers
 · 
146 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: La majorité des malades atteints d’une maladie de Crohn (MC) nécessitent le recours à un traitement chirurgical à un moment donné de leur évolution. Cependant, la récidive de la maladie est la règle. Certains facteurs peuvent influencer le temps de récurrence, ainsi que la sévérité des symptômes. La connaissance de ce risque de récidive justifie le concept d’être économe en termes de résection intestinale et de discuter après la chirurgie un traitement prophylactique des rechutes. Le but de cette revue est de faire le point sur les facteurs de risque de récidive postopératoire de la MC et les thérapeutiques prophylactiques de la récidive. Les facteurs favorisant la récidive postopératoire de la MC ont fait l’objet de nombreux travaux, mais les études contrôlées sont très rares et les résultats sont parfois contradictoires. La question principale est de savoir comment prévenir la récidive postopératoire ? À côté du rôle prouvé du tabac dont l’arrêt devrait être impératif, différents médicaments: les aminosalicylés et la sulfasalazine, les métronidazoles, les immunosuppresseurs, les probiotiques et les anti-TNF-alpha ont fait l’objet de plusieurs essais thérapeutiques contrôlés. Les médicaments candidats seraient les nitro-imidazolés et les immunosuppresseurs, et de nouvelles approches thérapeutiques évaluant mieux des thérapies biologiques devraient être réalisées afin de mieux élucider leur place thérapeutique. Les attitudes sont assez claires après résection iléale ou iléocolique, elles le sont moins après résection colique ou colorectale.
    Journal Africain d?Hépato-Gastroentérologie 01/2013; DOI:10.1007/s12157-013-0475-y
  • [Show abstract] [Hide abstract]
    ABSTRACT: To examine the association between single-nucleotide polymorphisms (SNPs) in CTGF (connective tissue growth factor) and patient outcomes after terminal ileal resection for Crohn's disease. The primary indication for intestinal resection in Crohn's disease is fibrostenotic terminal ileal disease. CTGF is a cytokine overexpressed in the intestine of patients with Crohn's disease that influences outcomes in other disease processes. DNA was extracted from formalin-fixed, paraffin-embedded tissue from 147 patients with Crohn's disease who had undergone terminal ileal resection between 1981 and 2009. Genotyping was performed for 4 CTGF SNPs (rs9402373, rs12526196, rs6918698, and rs9399005), which modulate nuclear factor binding and CTGF production, and a smad3 SNP (rs17293632) involved in the CTGF pathway. Patients were phenotyped using the Montreal Disease Classification. Sixty-seven of 147 patients (45.6%) were male; the mean age at diagnosis was 30.3 ± 12.6 years and the mean follow-up duration was 8.3 ± 7.1 years. Genotype-phenotype analysis demonstrated that the rs6918698GG genotype was associated with an older age of disease onset [>40 years; 30.6% vs 13.2%; odds ratio (OR): 2.891; 95% confidence interval (CI): 1.170-7.147). The rs9402373CC genotype was positively associated with type B1 disease (50.7% vs 26.3%; OR: 2.876; 95% CI: 1.226-6.743) and negatively associated with B2 disease (37.0% vs 65.0%; OR: 0.317; 95% CI: 0.144-0.699). None of the 5 SNPs assessed influenced clinical or surgical recurrence of Crohn's disease after intestinal resection. On multivariate analysis, male sex odds ratio (OR): 0.235; 95% CI: 0.073-0.755; P = 0.015] and never having smoked tobacco (OR: 0.249; 95% CI: 0.070-0.894; P = 0.033) reduced the risk, whereas having a prior appendectomy increased the risk (OR: 5.048; 95% CI: 1.632-15.617; P = 0.005) of surgical recurrence. These data implicate the rs6918698GG genotype with an age of disease onset of greater than 40 years in Crohn's disease whereas the rs9402373CC genotype is associated with a nonstricturing, nonpenetrating disease phenotype. CTGF SNPs do not influence the rate of recurrence after terminal ileal resection for Crohn's disease.
    Annals of surgery 11/2013; 258(5):767-774. DOI:10.1097/SLA.0000000000000247 · 7.19 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Crohn's disease is an immune-related disorder characterized by inflammation of the gastrointestinal mucosa, which can occur in any area throughout the digestive tract. This life-long disease commonly presents with abdominal pain, diarrhea, vomiting, and weight loss. While the exact etiology of this disease is largely unknown, it is thought to arise from an interaction between microbial, immunological, and environmental factors in a genetically susceptible host, whereby the immune system attacks the intestine as it cross reacts against gut microbial antigens. The study of genetic variants associated with Crohn's disease has shed light on our understanding of disease pathophysiology. A large number of genetic variants identified in Crohn's disease are related to genes targeting microbial recognition and bacterial wall sensing, the most common being NOD2/CARD15 gene. This review will discuss the recent advance in our knowledge of genetic variants of this disease and how they influence the disease course and prognosis.
    The Application of Clinical Genetics 07/2013; 6:25-32. DOI:10.2147/TACG.S33966